Stephanie Geisler

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.9K citations · Full text

Medicine, Molecular Biology, Oncology +16

Repeated observation of breast tumor subtypes in independent gene expression data sets

Thérese Sørlie, Robert Tibshirani, Joel S. Parker et al. · Proceedings of the National Academy of Sciences · 2003 · 5.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Turid Aas, Anne‐Lise Børresen, Stephanie Geisler et al. · Nature Medicine · 1996 · 742 citations

Medicine, Molecular Genetics, Oncology +14

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Jonathan R. Pollack, Charles M. Perou, Thérese Sørlie et al. · Nature Genetics · 1999 · 633 citations

Life Sciences, Genetics, Molecular Genetics +17

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Stephanie Geisler, Per Eystein Lønning, Hilde Johnsen et al. · PubMed · 2001 · 328 citations

Medicine, Oncology, Pharmacology +14